Let There Be Light: Genome Reduction Enables Bacillus subtilis to Produce Disulfide-Bonded Gaussia Luciferase
ACS Synthetic Biology · 2023
DOI: 10.1021/acssynbio.3c00444 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2023. Verfasst von Tobias Schilling und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30001, 9700RB Groningen, The…. Hauptthemen laut MEDLINE: Bacillus subtilis, Bacillus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Sklodowska-Curie Actions, Universities of Groningen and Greifswald.
Abstract (Originalsprache)
Bacillus subtilis is a major workhorse for enzyme production in industrially relevant quantities. Compared to mammalian-based expression systems, B. subtilis presents intrinsic advantages, such as high growth rates, high space-time yield, unique protein secretion capabilities, and low maintenance costs. However, B. subtilis shows clear limitations in the production of biopharmaceuticals, especially proteins from eukaryotic origin that contain multiple disulfide bonds. In the present study, we deployed genome minimization, signal peptide screening, and coexpression of recombinant thiol oxidases as strategies to improve the ability of B. subtilis to secrete proteins with multiple disulfide bonds. Different genome-reduced strains served as the chassis for expressing the model protein Gaussia Luciferase (GLuc), which contains five disulfide bonds. These chassis lack extracellular proteases, prophages, and key sporulation genes. Importantly, compared to the reference strain with a full-size genome, the best-performing genome-minimized strain achieved over 3000-fold increased secretion of active GLuc while growing to lower cell densities. Our results show that high-level GLuc secretion relates, at least in part, to the absence of major extracellular proteases. In addition, we show that the thiol-disulfide oxidoreductase requirements for disulfide bonding have changed upon genome reduction. Altogether, our results highlight genome-engineered Bacillus strains as promising expression platforms for proteins with multiple disulfide bonds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, P.O. Box 30001, 9700RB Groningen, The Netherlands.
- Institute of Microbiology Department of Microbial Proteomics, University of Greifswald, D-17489 Greifswald, Germany.
ORCID-Profile: Tobias Schilling, Sandra Maaβ, Dörte Becher, Jan Maarten van Dijl
Förderung
- H2020 Marie Sklodowska-Curie Actions
- Universities of Groningen and Greifswald
Zitieren
APA
Schilling, T., Ferrero-Bordera, B., Neef, J., Maaβ, S., Becher, D., & van Dijl, J. M. (2023). Let There Be Light: Genome Reduction Enables Bacillus subtilis to Produce Disulfide-Bonded Gaussia Luciferase. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.3c00444
Vancouver
Schilling T, Ferrero-Bordera B, Neef J, Maaβ S, Becher D, van Dijl JM. Let There Be Light: Genome Reduction Enables Bacillus subtilis to Produce Disulfide-Bonded Gaussia Luciferase. ACS Synthetic Biology. 2023. doi:10.1021/acssynbio.3c00444
BibTeX
@article{Schilling2023,
author = {Schilling, Tobias and Ferrero-Bordera, Borja and Neef, Jolanda and Maaβ, Sandra and Becher, Dörte and van Dijl, Jan Maarten},
title = {Let There Be Light: Genome Reduction Enables Bacillus subtilis to Produce Disulfide-Bonded Gaussia Luciferase},
journal = {ACS Synthetic Biology},
year = {2023},
doi = {10.1021/acssynbio.3c00444}
}
EUVIMED